sur EnVVeno Medical Corporation (NASDAQ:NVNO)
EnVVeno Medical Featured in Virtual Investor Conference
enVVeno Medical Corporation, based in Irvine, California, announced its participation in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference. CEO Rob Berman highlighted his dedication to the company and discussed the development of enVVeno's products.
Participants can access the on-demand video webcast at virtualinvestorco.com and the company's website. enVVeno, listed on NASDAQ as NVNO, is advancing solutions for deep venous disease with their products VenoValve® and enVVe®. These innovations are aimed at treating Chronic Venous Insufficiency (CVI) by acting as one-way valves to aid blood flow.
The VenoValve® is undergoing a pivotal study, while enVVe® is in final testing stages for trial approval.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de EnVVeno Medical Corporation